9 May 2023

Kanabo Group plc

("Kanabo", the "Group" or the "Company")

Appointment of Ian Mattioli MBE as Non-Executive Chair of the Board

Kanabo Group plc (LSE: KNB), the patient focused healthcare technology and medicinal cannabis company, announces the appointment of Ian Mattioli MBE as Non-Executive Chair with immediate effect.

Ian Mattioli, co-founder and CEO of a leading UK pensions and wealth management consultancy, brings extensive experience in financial services, wealth management and capital markets.

Key Highlights:

·    Co-founder and CEO of Mattioli Woods PLC, a leading UK pensions and wealth management consultancy.

·    Ian created and founded the property business Custodian Property Income REIT plc which listed on the London Stock Exchange Main Market in 2014.

·    Recipient of London Stock Exchange AIM Entrepreneur of the Year and CEO of the Year in the 2018 City of London Wealth Management Awards.

Mr David Tsur, who has served as the Kanabo's Non-Executive Chair since the Company's admission to the London Stock Exchange in February 2021, will transition to Deputy Chair following Ian Mattioli's appointment.

David Tsur, Deputy Chair of Kanabo:

"We are delighted to welcome Ian to the leadership team as we embark on a year of growth and expansion into new markets and services. His experience and understanding of London's capital markets will be invaluable as we work to advance our strategic goals for the company. Since the Company's admission to the London Stock Exchange, we have achieved numerous significant milestones, including launching two medical cannabis products, building a comprehensive supply chain, acquiring The GP Service, and launching Treat-It, our innovative digital health platform for pain management."

Ian Mattioli MBE, added:

"I am delighted to join Kanabo as a Chair and am impressed with the Company's commitment to personalised, accessible, and affordable healthcare. With its leading-edge technology and disruptive products, Kanabo is poised for significant growth in the digital health sector. I am keen to contribute my experience and knowledge to support Kanabo in its future success."

Additional information about Ian Mattioli MBE

Ian Mattioli brings considerable financial services, wealth management, property and capital markets experience to the Group. Ian Mattioli co-founded the wealth management group, Mattioli Woods PLC ("Mattioli Woods"), in 1991 and has held the role of CEO since Mattioli Woods was admitted to AIM in 2005. He is responsible for the vision and operational management of the Group. Mattioli Woods is one of the UK's leading consultancies in the provision of pensions and wealth management services for controlling directors, professional persons, owner-managed businesses, and small-to-medium-sized PLCs.

Ian Mattioli has received many accolades for his business acumen, including being awarded the London Stock Exchange AIM Entrepreneur of the Year award and CEO of the Year in the 2018 City of London Wealth Management Awards. Ian Mattioli was awarded an MBE for services to business and the community in Leicestershire in the Queen's 2017 Honours List. In 2022, the University of Leicester awarded Ian Mattioli an honorary degree (Doctor of Laws).

Ian Mattioli is currently Chief Executive Officer of Mattioli Woods Plc, and Non-Executive Director of Custodian Property Income REIT Plc.

Save for the information disclosed below, Kanabo confirms there is no further information to be disclosed under the requirements of Listing Rule 9.6.13 in relation to the appointment of Ian Mattioli as Non-Executive Director.

Ian Mattioli currently holds 500,000 ordinary shares in the Company, representing 0.1% of the issued share capital.

Enquiries:

About Kanabo Group Plc

Kanabo Group Plc (LSE:KNB) is a healthtech company committed to revolutionising patient care through its innovative technology platform and disruptive product offerings. Since its inception in 2017, Kanabo has been focused on researching, developing, and commercialising regulated medicinal cannabis-derived formulations and therapeutic inhalation devices.

Kanabo's NHS-approved online telehealth platform, The GP Service, provides patients with video consultations, online prescriptions, and primary care services. The Company is a leader in its field, focusing on improving patient outcomes and providing more accessible healthcare experiences.

In March 2023, Kanabo successfully launched its Pain Clinic, Treat It, under the expert guidance of its technological and product expertise. Treat It initially focuses on chronic pain management using plant-based medicine and treatments that are currently unavailable through traditional channels.

At Kanabo Group Plc, we are dedicated to providing patients with the highest quality medical treatments and more accessible healthcare experiences.

Visit www.kanabogroup.com for more information.